• LAST PRICE
    4.7700
  • TODAY'S CHANGE (%)
    Trending Down-0.3200 (-6.2868%)
  • Bid / Lots
    4.7600/ 2
  • Ask / Lots
    4.9100/ 1
  • Open / Previous Close
    5.0300 / 5.0900
  • Day Range
    Low 4.7500
    High 5.0500
  • 52 Week Range
    Low 2.2500
    High 7.9900
  • Volume
    393,178
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 5.09
TimeVolumeDCTH
09:32 ET20165.03
09:34 ET21005.01
09:36 ET32505
09:38 ET21004.93
09:39 ET146954.89
09:41 ET28104.9
09:43 ET12004.9
09:48 ET5004.9335
09:52 ET1004.965
09:56 ET2004.975
09:57 ET448804.77
09:59 ET20304.76
10:01 ET11504.87
10:03 ET3204.87
10:06 ET10004.86
10:08 ET20004.85
10:10 ET13004.84
10:12 ET5004.86
10:14 ET124384.78
10:15 ET6004.8
10:17 ET58804.84
10:19 ET6504.8
10:21 ET4504.85
10:24 ET1004.84
10:28 ET1004.84
10:30 ET1004.88
10:32 ET16294.84
10:33 ET6004.845
10:35 ET41604.845
10:37 ET7844.85
10:39 ET7004.85
10:42 ET124884.81
10:46 ET6004.85
10:48 ET6004.865
10:50 ET6004.865
10:51 ET34674.8543
10:53 ET19004.88
10:55 ET8004.87
10:57 ET23004.87
11:00 ET38484.9
11:04 ET4004.91
11:06 ET10004.92
11:08 ET113794.86
11:09 ET63954.86
11:13 ET20254.87
11:15 ET29004.83
11:20 ET4944.84
11:26 ET2504.8641
11:31 ET24004.86
11:36 ET10704.85
11:38 ET6124.85
11:40 ET25004.85
11:42 ET35574.8453
11:44 ET1004.84
11:47 ET2004.85
11:51 ET1004.85
11:54 ET10754.84
11:56 ET21004.84
11:58 ET59444.87
12:00 ET1004.87
12:02 ET1004.86
12:07 ET1004.86
12:12 ET4004.86
12:14 ET18004.8673
12:18 ET2004.865
12:27 ET2004.87
12:30 ET14514.895
12:32 ET52004.86
12:38 ET4004.885
12:39 ET1004.9
12:43 ET27004.91
12:45 ET6004.92
12:50 ET16624.88
12:52 ET2004.8854
01:06 ET5004.899
01:08 ET19094.89
01:10 ET11004.89
01:12 ET1004.9
01:14 ET1004.88
01:21 ET3004.9
01:24 ET1004.9
01:26 ET1004.9
01:28 ET7374.9
01:32 ET4174.9
01:33 ET4004.9
01:37 ET1004.9
01:39 ET38954.9
01:46 ET3004.9
01:50 ET5004.89
01:51 ET2004.9
01:53 ET4004.89
02:00 ET3004.87
02:06 ET5004.85
02:08 ET15004.84
02:11 ET3004.84
02:13 ET2004.84
02:15 ET1004.84
02:18 ET297404.78
02:22 ET16044.79
02:24 ET100614.75
02:27 ET63904.7898
02:33 ET19124.78
02:36 ET7004.79
02:38 ET2004.8
02:40 ET20004.81
02:42 ET27904.8
02:45 ET15594.81
02:51 ET1004.84
02:56 ET9004.86
02:58 ET1004.866
03:00 ET1004.8694
03:02 ET4004.87
03:03 ET6954.84
03:07 ET101294.84
03:09 ET6004.87
03:12 ET14004.84
03:16 ET26504.84
03:18 ET1004.84
03:21 ET1004.85
03:23 ET29004.845
03:25 ET124234.85
03:27 ET3004.84
03:30 ET22634.84
03:34 ET18004.82
03:36 ET5784.82
03:38 ET4004.81
03:43 ET11374.82
03:45 ET17004.83
03:48 ET77254.795
03:50 ET5004.815
03:52 ET80094.795
03:54 ET36064.81
03:56 ET56184.7959
03:57 ET142864.81
03:59 ET55454.77
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesDCTH
Delcath Systems Inc
116.7M
-1.6x
---
United StatesVANI
Vivani Medical Inc
101.7M
-3.2x
---
United StatesIRME
IR-MED Inc
91.2M
-15.6x
---
United StatesMYO
Myomo Inc
99.7M
-12.0x
---
United StatesXAIR
Beyond Air Inc
79.9M
-0.8x
---
United StatesKRMD
KORU Medical Systems Inc
104.0M
-13.0x
---
As of 2024-03-29

Company Information

Delcath Systems, Inc. is an interventional oncology company. The Company is focused on the treatment of primary and metastatic liver cancers. The Company’s proprietary products, HEPZATO Kit (melphalan hydrochloride for Injection/Hepatic Delivery System) and CHEMOSAT Hepatic Delivery System for Melphalan percutaneous hepatic perfusion (PHP) are designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects during a PHP procedure. HEPZATO Kit is comprised of the chemotherapeutic drug melphalan and Delcath’s proprietary Hepatic Delivery System (HDS). In Europe, the device-only configuration of the HDS is regulated as a Class III medical device and is sold under the trade name CHEMOSAT Hepatic Delivery System for Melphalan (CHEMOSAT), where it has been used in the conduct of percutaneous hepatic perfusion procedures at medical centers to treat a range of cancers of the liver.

Contact Information

Headquarters
566 Queensbury AvenueQUEENSBURY, NY, United States 12804
Phone
518-743-8892
Fax
212-489-2102

Executives

Independent Chairman of the Board
John Sylvester
Chief Executive Officer, Director
Gerard Michel
Chief Operating Officer
Martha Rook
Executive Vice President - Global Head of Operations
John Purpura
Senior Vice President - Finance, Chief Accounting Officer, Executive Officer
Sandra Pennell

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$109.3M
Revenue (TTM)
$2.1M
Shares Outstanding
22.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.53
EPS
$-2.98
Book Value
$0.69
P/E Ratio
-1.6x
Price/Sales (TTM)
52.9
Price/Cash Flow (TTM)
---
Operating Margin
-1,849.01%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.